LIPOCINE INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
LIPOCINE INC. (LPCN) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $17.40 thousand for the 21-month period ending 2013-06-30, per its 10-Q filed 2013-07-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2013-07-09
- LIPOCINE INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2013-06-30 was $2.65K.
- LIPOCINE INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2013-03-31 was $3.10K.
- LIPOCINE INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2012-12-31 was $4.90K, a 33.49% decline year-over-year.
- LIPOCINE INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2012-09-30 was $2.85K.
- LIPOCINE INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2012 was $4.29K, a 41.79% decline from fiscal 2011.
- LIPOCINE INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2011 was $7.37K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 15 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 18 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 21 month |
|---|---|---|---|---|---|---|---|
| 2013-06-30 | $2.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-09 | $5.75K 10-Q · filed 2013-07-09 | $10.65K derived: sum of 3 quarters · filed 2013-07-09 | $13.50K derived: sum of 4 quarters · filed 2013-07-09 | $17.40K 10-Q · filed 2013-07-09 | ||
| 2013-03-31 | $3.10K 10-Q · filed 2013-04-24 | $8.00K derived: sum of 2 quarters · filed 2013-04-24 | $10.85K derived: sum of 3 quarters · filed 2013-04-24 | $7.62K derived: sum of 4 quarters · filed 2013-07-09 | $14.75K 10-Q · filed 2013-04-24 | ||
| 2012-12-31 | $4.90K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $7.75K derived: sum of 2 quarters · filed 2013-02-26 | $4.53K derived: sum of 3 quarters · filed 2013-07-09 | $4.29K 10-K · filed 2013-02-26 | $11.65K 10-K · filed 2013-02-26 | ||
| 2012-09-30 | $2.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-26 | -$372.00 derived: sum of 2 quarters · filed 2013-07-09 | -$612.00 10-Q · filed 2012-10-26 | $6.75K 10-Q · filed 2012-10-26 | |||
| 2012-06-30 | -$3.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-09 | -$3.47K 10-Q · filed 2013-07-09 | $3.90K derived: sum of 3 quarters · filed 2013-07-09 | ||||
| 2012-03-31 | -$240.00 10-Q · filed 2013-04-24 | $7.13K derived: sum of 2 quarters · filed 2013-04-24 | |||||
| 2011-12-31 | $7.37K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $7.37K 10-K · filed 2013-02-26 | |||||
| 2011-09-30 | $0.00 10-Q · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |